![Gregory D. Plowman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory D. Plowman
Direktor/Vorstandsmitglied bei
New York Biotechnology Association, Inc.
Profil
Gregory D.
Plowman is currently a Director at New York Biotechnology Association, Inc., AurKa Pharma, Inc., and Acanthas Pharma, Inc. He was previously a Senior Vice President at ImClone LLC, Vice President-Oncology Research at Eli Lilly & Co., and Chief Technology Officer at Exelixis, Inc. Plowman holds a doctorate from the University of Washington and an undergraduate degree from Whitman College.
Aktive Positionen von Gregory D. Plowman
| Unternehmen | Position | Beginn |
|---|---|---|
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Direktor/Vorstandsmitglied | - |
Acanthas Pharma, Inc.
 Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 19.03.2019 |
Ehemalige bekannte Positionen von Gregory D. Plowman
| Unternehmen | Position | Ende |
|---|---|---|
AurKa Pharma, Inc.
 AurKa Pharma, Inc. BiotechnologyHealth Technology Develops medication for cancer treatment | Direktor/Vorstandsmitglied | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Gregory D. Plowman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitman College
 Whitman College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
AurKa Pharma, Inc.
AurKa Pharma, Inc. BiotechnologyHealth Technology Develops medication for cancer treatment | Health Technology |
Acanthas Pharma, Inc.
Acanthas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wählen Sie MarketScreener 
